Hyperphosphatemia is a combined function of high serum PTH and high dietary protein intake in dialysis patients

Kidney International Supplements

Volumn 3, Issue 5, 2013, Pages 462-468

  Streja, Elani ^a   Lau, Wei Ling ^a   Goldstein, Leanne ^a   Sim, John J ^b   Molnar, Miklos Z ^a   Nissenson, Allen R ^c,d   Kovesdy, Csaba P ^e,f   Kalantar Zadeh, Kamyar ^a,g  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b KAISER PERMANENTE   (United States)

^c DaVita   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Chronic kidney disease (CKD); Hemodialysis; Hyperphosphatemia; Parathyroid hormone; Phosphorus; Protein intake

Indexed keywords

ALBUMIN; ALKALINE PHOSPHATASE; BICARBONATE; CALCIUM; CREATININE; FERRITIN; HEMOGLOBIN; PARATHYROID HORMONE; PHOSPHORUS;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; BICARBONATE BLOOD LEVEL; CALCIUM BLOOD LEVEL; CARDIOVASCULAR DISEASE; CASE MIX; CATABOLISM; CEREBROVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONGESTIVE HEART FAILURE; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FERRITIN BLOOD LEVEL; HEMODIALYSIS PATIENT; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERPARATHYROIDISM; HYPERPHOSPHATEMIA; HYPERTENSION; HYPOTHESIS; INSURANCE; IRON BINDING CAPACITY; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MARRIAGE; MIDDLE AGED; PARATHYROID HORMONE BLOOD LEVEL; PATIENT SELECTION; PERIPHERAL VASCULAR DISEASE; PHOSPHATE BLOOD LEVEL; PREVALENCE; PROTEIN INTAKE; RENAL REPLACEMENT THERAPY; SECONDARY HYPERPARATHYROIDISM; TREATMENT DURATION;

EID: 84896692197     PISSN: 21571724     EISSN: 21571716     Source Type: Journal    
DOI: 10.1038/kisup.2013.96     Document Type: Article

References (44)

1. Sim JJ, Bhandari SK, Smith N et al. Phosphorus and risk of renal failure in subjects with normal renal function. Am J Med 2013; 126: 311-318.
2. Li J, Molnar MZ, Zaritsky JJ et al. Correlates of parathyroid hormone concentration in hemodialysis patients. Nephrol Dial Transplant 2013; 28: 1516-1525.
3. Lertdumrongluk P, Rhee CM, Park J et al. Association of serum phosphorus concentration with mortality in elderly and nonelderly hemodialysis patients. J Ren Nutr 2013 pii: S1051-2276(13)00044-7. doi:10.1053/j.jrn.2013.01.018. Epub ahead of print.
4. Kalantar-Zadeh K, Ikizler TA. Let them eat during dialysis: an overlooked opportunity to improve outcomes in maintenance hemodialysis patients. J Ren Nutr 2013; 23: 157-163.
5. Cupisti A, Kalantar-Zadeh K. Management of natural and added dietary phosphorus burden in kidney disease. Semin Nephrol 2013; 33: 180-190.
6. Cupisti A, Benini O, Ferretti V et al. Novel differential measurement of natural and added phosphorus in cooked ham with or without preservatives. J Ren Nutr 2012; 22: 533-540.
7. Sampaio MS, Molnar MZ, Kovesdy CP et al. Association of pretransplant serum phosphorus with posttransplant outcomes. Clin J Am Soc Nephrol 2011; 6: 2712-2721.
8. Qunibi W, Kalantar-Zadeh K. Target levels for serum phosphorus and parathyroid hormone. Semin Dial 2011; 24: 29-33.
9. Hruska K, Mathew S, Lund R et al. Hyperphosphatemia of chronic kidney disease. Kidney Int 2008; 74: 148-157.
10. Isakova T, Wahl P, Vargas GS et al. Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney Int 2011; 79: 1370-1378.
11. Kestenbaum B, Sampson J, Rudser K et al. Serum phosphate levels and mortality risk among people with chronic kidney disease. J Am Soc Nephrol 2005; 16: 520-528.
12. Kovesdy CP, Anderson JE, Kalantar-Zadeh K. Outcomes associated with serum phosphorus level in males with non-dialysis dependent chronic kidney disease. Clin Nephrol 2010; 73: 268-275.
13. Block GA, Hulbert-Shearon TE, Levin NW et al. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 1998; 31: 607-617.
14. Young EW, Albert JM, Satayathum S et al. Predictors and consequences of altered mineral metabolism: the dialysis outcomes and practice patterns study. Kidney Int 2005; 67: 1179-1187.
15. Kalantar-Zadeh K, Kuwae N, Regidor DL et al. Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int 2006; 70: 771-780.
16. Tentori F, Blayney MJ, Albert JM et al. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and pth: The dialysis outcomes and practice patterns study (DOPPS). Am J Kidney Dis 2008; 52: 519-530.
17. Giachelli C. Vascular calcification: in vitro evidence for the role of inorganic phosphate. J Am Soc Nephrol 2003; 14: S300-S304.
18. Jono S, McKee M, Murry C et al. Phosphate regulation of vascular smooth muscle cell calcification. Circ Res 2000; 87: E10-E17.
19. Reynolds J, Joannides A, Skepper J et al. Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD. J Am Soc Nephrol 2004; 15: 2857-2867.
20. Shroff R, McNair R, Skepper J et al. Chronic mineral dysregulation promotes vascular smooth muscle cell adaptation and extracellular matrix calcification. J Am Soc Nephrol 2010; 21: 103-112.
21. El-Abbadi MM, Pai AS, Leaf EM et al. Phosphate feeding induces arterial medial calcification in uremic mice: role of serum phosphorus, fibroblast growth factor-23, and osteopontin. Kidney Int 2009; 75: 1297-1307.
22. Mizobuchi M, Ogata H, Hatamura I et al. Up-regulation of cbfa1 and pit-1 in calcified artery of uraemic rats with severe hyperphosphataemia and secondary hyperparathyroidism. 2006; 21: 911-916.
23. Schwarz S, Trivedi BK, Kalantar-Zadeh K et al. Association of disorders in mineral metabolism with progression of chronic kidney disease. Clin J Am Soc Nephrol 2006; 1: 825-831.
24. Kovesdy CP, Kalantar-Zadeh K. Serum phosphorus and the risk of progression of chronic kidney disease. Nephrol Dial Transplant 2007; 22: 3679-3680.
25. Lorenzo V, Martín M, Rufino M et al. Protein intake, control of serum phosphorus, and relatively low levels of parathyroid hormone in elderly hemodialysis patients. Am J Kidney Dis 2001; 37: 1260-1266.
26. Noori N, Kalantar-Zadeh K, Kovesdy CP et al. Association of dietary phosphorus intake and phosphorus to protein ratio with mortality in hemodialysis patients. Clin J Am Soc Nephrol 2010; 5: 683-692.
27. Shinaberger CS, Kilpatrick RD, Regidor DL et al. Longitudinal associations between dietary protein intake and survival in hemodialysis patients. Am J Kidney Dis 2006; 48: 37-49.
28. Shinaberger CS, Greenland S, Kopple JD et al. Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease? Am J Clin Nutr 2008; 88: 1511-1518.
29. Frazao JM, Braun J, Messa P et al. Is serum phosphorus control related to parathyroid hormone control in dialysis patients with secondary hyperparathyroidism? BMC Nephrol 2012; 13: 76.
30. Wesseling-Perry K, Harkins GC, Wang HJ et al. The calcemic response to continuous parathyroid hormone (pth)(1-34) infusion in end-stage kidney disease varies according to bone turnover: a potential role for pth(7-84). J Clin Endocrinol Metab 2010; 95: 2772-2780.
31. Kovesdy CP, Kopple JD, Kalantar-Zadeh K. Management of proteinenergy wasting in non-dialysis-dependent chronic kidney disease: reconciling low protein intake with nutritional therapy. Am J Clin Nutr 2013; 97: 1163-1177.
32. Bradbury BD, Fissell RB, Albert JM et al. Predictors of early mortality among incident us hemodialysis patients in the dialysis outcomes and practice patterns study (dopps). Clin J Am Soc Nephrol 2007; 2: 89-99.
33. Quarles LD, Lobaugh B, Murphy G. Intact parathyroid hormone overestimates the presence and severity of parathyroid-mediated osseous abnormalities in uremia. J Clin Endocrinol Metab 1992; 75: 145-150.
34. Lukowsky LR, Molnar MZ, Zaritsky JJ et al. Mineral and bone disorders and survival in hemodialysis patients with and without polycystic kidney disease. Nephrol Dial Transplant 2012; 27: 2899-2907.
35. Feroze U, Molnar MZ, Dukkipati R et al. Insights into nutritional and inflammatory aspects of low parathyroid hormone in dialysis patients. J Ren Nutr 2011; 21: 100-104.
36. Qureshi AR, Alvestrand A, Divino-Filho JC et al. Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients. J Am Soc Nephrol 2002; 13(Suppl 1): S28-S36.
37. Kalantar-Zadeh K, Gutekunst L, Mehrotra R et al. Understanding sources of dietary phosphorus in the treatment of patients with chronic kidney disease. Clin J Am Soc Nephrol 2010; 5: 519-530.
38. Zitt E, Fouque D, Jacobson SH et al. Serum phosphorus reduction in dialysis patients treated with cinacalcet for secondary hyperparathyroidism results mainly from parathyroid hormone reduction. Clin Kidney J 2013; 6: 287-294.
39. Sato T, Tominaga Y, Ueki T et al. Total parathyroidectomy reduces elevated circulating fibroblast growth factor 23 in advanced secondary hyperparathyroidism. Am J Kidney Dis 2004; 44: 481-487.
40. Hernández A, Concepción MT, Rodríguez M et al. High phosphorus diet increases ProprePTH mRNA independent of calcium and calcitriol in normal rats. Kidney Int 1996; 50: 1872-1878.
41. Martin DR, Ritter CS, Slatopolsky E et al. Acute regulation of parathyroid hormone by dietary phosphate. Am J Physiol Endocrinol Metab 2005; 289: E729-E734.
42. Kalantar-Zadeh K, Regidor DL, Kovesdy CP et al. Fluid retention is associated with cardiovascular mortality in patients undergoing longterm hemodialysis. Circulation 2009; 119: 671-679.
43. Mehrotra R, Duong U, Jiwakanon S et al. Serum albumin as a predictor of mortality in peritoneal dialysis: comparisons with hemodialysis. Am J Kidney Dis 2011; 58: 418-428.
44. Durrleman S, Simon R. Flexible regression models with cubic splines. Stat Med 1989; 8: 551-561.